Pulmonx Corp (LUNG)
6.79
+0.37
(+5.76%)
USD |
NASDAQ |
Nov 22, 16:00
6.80
+0.01
(+0.15%)
After-Hours: 20:00
Pulmonx Cash from Financing (Quarterly): 0.459M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.459M |
| June 30, 2024 | -0.022M |
| March 31, 2024 | 0.864M |
| December 31, 2023 | 0.017M |
| September 30, 2023 | 0.571M |
| June 30, 2023 | 0.092M |
| March 31, 2023 | 20.72M |
| December 31, 2022 | 0.067M |
| September 30, 2022 | 0.906M |
| June 30, 2022 | 0.131M |
| Date | Value |
|---|---|
| March 31, 2022 | 1.315M |
| December 31, 2021 | 0.15M |
| September 30, 2021 | 1.00M |
| June 30, 2021 | 3.293M |
| March 31, 2021 | 0.013M |
| December 31, 2020 | 199.76M |
| September 30, 2020 | 2.359M |
| June 30, 2020 | 31.40M |
| March 31, 2020 | 1.308M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.022M
Minimum
Jun 2024
199.76M
Maximum
Dec 2020
13.92M
Average
0.864M
Median
Mar 2024
Cash from Financing (Quarterly) Benchmarks
| Cutera Inc | -0.419M |
| IRIDEX Corp | 2.823M |
| Stereotaxis Inc | 0.08M |
| Electromed Inc | -4.467M |
| Myomo Inc | -0.1995M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.242M |
| Cash from Investing (Quarterly) | 6.751M |
| Free Cash Flow | -34.79M |
| Free Cash Flow Per Share (Quarterly) | -0.195 |
| Free Cash Flow to Equity (Quarterly) | -7.691M |
| Free Cash Flow to Firm (Quarterly) | -7.658M |
| Free Cash Flow Yield | -13.20% |